Psoriasis-Liver-Methotrexate Interactions

G. Weinstein, H. Roenigk, H. Maibach, J. Cosmides, K. Halprin, M. Millard, J. Almeyda, R. Auerbach, H. Tobias, W. Bergfeld, D. Clyde, M. Dahl, P. Frost, Eugene R Schiff, R. Krueger, J. Tindall, J. Lee, A. Lundquist, F. Schaffner, P. ScheuerH. Zachariae

Research output: Contribution to journalArticle

170 Citations (Scopus)

Abstract

An international cooperative study was organized to evaluate whether the treatment of severe psoriasis with methotrexate significantly affects the liver of these patients. From a study population of 550 patients, 742 liver biopsy specimens together with pertinent clinical and laboratory data were evaluated as a function of methotrexate usage. Factors found to be significantly associated with histologic liver damage include: increased alcohol intake, the daily orally administered methotrexate dosage schedule, obesity, and diabetes. The evidence implicating increasing cumulative methotrexate dosage as a cause of hepatic fibrosis is not clear. Of 247 patients with biopsyproven fibrosis or cirrhosis, 88 patients had no recorded abnormalities in history, physical examination, or laboratory test results which casts serious doubt on the reliability of detecting fibrosis or cirrhosis without a liver biopsy.

Original languageEnglish (US)
Pages (from-to)36-42
Number of pages7
JournalArchives of Dermatology
Volume108
Issue number1
DOIs
StatePublished - 1973

Fingerprint

Psoriasis
Methotrexate
Fibrosis
Liver
Biopsy
Physical Examination
Appointments and Schedules
Obesity
History
Alcohols
Population
Therapeutics

ASJC Scopus subject areas

  • Dermatology

Cite this

Weinstein, G., Roenigk, H., Maibach, H., Cosmides, J., Halprin, K., Millard, M., ... Zachariae, H. (1973). Psoriasis-Liver-Methotrexate Interactions. Archives of Dermatology, 108(1), 36-42. https://doi.org/10.1001/archderm.1973.01620220008002

Psoriasis-Liver-Methotrexate Interactions. / Weinstein, G.; Roenigk, H.; Maibach, H.; Cosmides, J.; Halprin, K.; Millard, M.; Almeyda, J.; Auerbach, R.; Tobias, H.; Bergfeld, W.; Clyde, D.; Dahl, M.; Frost, P.; Schiff, Eugene R; Krueger, R.; Tindall, J.; Lee, J.; Lundquist, A.; Schaffner, F.; Scheuer, P.; Zachariae, H.

In: Archives of Dermatology, Vol. 108, No. 1, 1973, p. 36-42.

Research output: Contribution to journalArticle

Weinstein, G, Roenigk, H, Maibach, H, Cosmides, J, Halprin, K, Millard, M, Almeyda, J, Auerbach, R, Tobias, H, Bergfeld, W, Clyde, D, Dahl, M, Frost, P, Schiff, ER, Krueger, R, Tindall, J, Lee, J, Lundquist, A, Schaffner, F, Scheuer, P & Zachariae, H 1973, 'Psoriasis-Liver-Methotrexate Interactions', Archives of Dermatology, vol. 108, no. 1, pp. 36-42. https://doi.org/10.1001/archderm.1973.01620220008002
Weinstein G, Roenigk H, Maibach H, Cosmides J, Halprin K, Millard M et al. Psoriasis-Liver-Methotrexate Interactions. Archives of Dermatology. 1973;108(1):36-42. https://doi.org/10.1001/archderm.1973.01620220008002
Weinstein, G. ; Roenigk, H. ; Maibach, H. ; Cosmides, J. ; Halprin, K. ; Millard, M. ; Almeyda, J. ; Auerbach, R. ; Tobias, H. ; Bergfeld, W. ; Clyde, D. ; Dahl, M. ; Frost, P. ; Schiff, Eugene R ; Krueger, R. ; Tindall, J. ; Lee, J. ; Lundquist, A. ; Schaffner, F. ; Scheuer, P. ; Zachariae, H. / Psoriasis-Liver-Methotrexate Interactions. In: Archives of Dermatology. 1973 ; Vol. 108, No. 1. pp. 36-42.
@article{a95bd22ca70d47c68f9ce2dfd5984bf4,
title = "Psoriasis-Liver-Methotrexate Interactions",
abstract = "An international cooperative study was organized to evaluate whether the treatment of severe psoriasis with methotrexate significantly affects the liver of these patients. From a study population of 550 patients, 742 liver biopsy specimens together with pertinent clinical and laboratory data were evaluated as a function of methotrexate usage. Factors found to be significantly associated with histologic liver damage include: increased alcohol intake, the daily orally administered methotrexate dosage schedule, obesity, and diabetes. The evidence implicating increasing cumulative methotrexate dosage as a cause of hepatic fibrosis is not clear. Of 247 patients with biopsyproven fibrosis or cirrhosis, 88 patients had no recorded abnormalities in history, physical examination, or laboratory test results which casts serious doubt on the reliability of detecting fibrosis or cirrhosis without a liver biopsy.",
author = "G. Weinstein and H. Roenigk and H. Maibach and J. Cosmides and K. Halprin and M. Millard and J. Almeyda and R. Auerbach and H. Tobias and W. Bergfeld and D. Clyde and M. Dahl and P. Frost and Schiff, {Eugene R} and R. Krueger and J. Tindall and J. Lee and A. Lundquist and F. Schaffner and P. Scheuer and H. Zachariae",
year = "1973",
doi = "10.1001/archderm.1973.01620220008002",
language = "English (US)",
volume = "108",
pages = "36--42",
journal = "JAMA Dermatology",
issn = "2168-6068",
publisher = "American Medical Association",
number = "1",

}

TY - JOUR

T1 - Psoriasis-Liver-Methotrexate Interactions

AU - Weinstein, G.

AU - Roenigk, H.

AU - Maibach, H.

AU - Cosmides, J.

AU - Halprin, K.

AU - Millard, M.

AU - Almeyda, J.

AU - Auerbach, R.

AU - Tobias, H.

AU - Bergfeld, W.

AU - Clyde, D.

AU - Dahl, M.

AU - Frost, P.

AU - Schiff, Eugene R

AU - Krueger, R.

AU - Tindall, J.

AU - Lee, J.

AU - Lundquist, A.

AU - Schaffner, F.

AU - Scheuer, P.

AU - Zachariae, H.

PY - 1973

Y1 - 1973

N2 - An international cooperative study was organized to evaluate whether the treatment of severe psoriasis with methotrexate significantly affects the liver of these patients. From a study population of 550 patients, 742 liver biopsy specimens together with pertinent clinical and laboratory data were evaluated as a function of methotrexate usage. Factors found to be significantly associated with histologic liver damage include: increased alcohol intake, the daily orally administered methotrexate dosage schedule, obesity, and diabetes. The evidence implicating increasing cumulative methotrexate dosage as a cause of hepatic fibrosis is not clear. Of 247 patients with biopsyproven fibrosis or cirrhosis, 88 patients had no recorded abnormalities in history, physical examination, or laboratory test results which casts serious doubt on the reliability of detecting fibrosis or cirrhosis without a liver biopsy.

AB - An international cooperative study was organized to evaluate whether the treatment of severe psoriasis with methotrexate significantly affects the liver of these patients. From a study population of 550 patients, 742 liver biopsy specimens together with pertinent clinical and laboratory data were evaluated as a function of methotrexate usage. Factors found to be significantly associated with histologic liver damage include: increased alcohol intake, the daily orally administered methotrexate dosage schedule, obesity, and diabetes. The evidence implicating increasing cumulative methotrexate dosage as a cause of hepatic fibrosis is not clear. Of 247 patients with biopsyproven fibrosis or cirrhosis, 88 patients had no recorded abnormalities in history, physical examination, or laboratory test results which casts serious doubt on the reliability of detecting fibrosis or cirrhosis without a liver biopsy.

UR - http://www.scopus.com/inward/record.url?scp=84948007868&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84948007868&partnerID=8YFLogxK

U2 - 10.1001/archderm.1973.01620220008002

DO - 10.1001/archderm.1973.01620220008002

M3 - Article

C2 - 4716740

AN - SCOPUS:84948007868

VL - 108

SP - 36

EP - 42

JO - JAMA Dermatology

JF - JAMA Dermatology

SN - 2168-6068

IS - 1

ER -